| Name | Rotech |
|---|---|
| Organization Name | Rotech Oxygen And Medical Equipment Inc |
| Location | 7033 Commonwealth Ave, Ste 9, Jacksonville, Florida 32220 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (904) 448-5353 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Adhering to a Mediterranean-type diet (MedDi) does not appear associated with the time to clinical onset of Huntington disease (phenoconversion), according to a study by Karen Marder, M.D., M.P.H., of Columbia University College of Physicians and Surgeons, New York, N.Y., and colleagues.
ZyStor Therapeutics, Inc., a biotechnology company developing a new class of targeted protein therapeutics for the treatment of Lysosomal Storage Diseases using the Company's proprietary Glycosylation Independent Lysosomal Targeting technology, today announced that it has received clearance from the U. S. Food and Drug Administration to proceed into a clinical trial for its first drug candidate, ZC-701, an enzyme replacement therapy for the treatment of Pompe disease.
As of 24 May 2004, the health authorities of Yambio County have reported a total of 19 cases, including 4 deaths, of Ebola haemorrhagic fever (EHF) in Yambio, Western Equatoria, south Sudan.
Targeted neuromodulation tailored to individual patients' distinctive symptoms is an increasingly common way of correcting misfiring brain circuits in people with epilepsy or Parkinson's disease.
Two studies in the November 17 issue of JAMA examine the change in prostate-specific antigen (PSA) screening and prostate cancer incidence before and after the 2012 U.S. Preventive Services Task Force (USPSTF) screening recommendations.
› Verified 5 days ago
| NPI Number | 1629058912 |
| Organization Name | ROTECH OXYGEN AND MEDICAL EQUIPMENT INC |
| Doing Business As | ROTECH |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 7033 Commonwealth Ave, Suite 9, Jacksonville, FL 32220 |
| Phone Number | 904-448-5353 |
News Archive
Adhering to a Mediterranean-type diet (MedDi) does not appear associated with the time to clinical onset of Huntington disease (phenoconversion), according to a study by Karen Marder, M.D., M.P.H., of Columbia University College of Physicians and Surgeons, New York, N.Y., and colleagues.
ZyStor Therapeutics, Inc., a biotechnology company developing a new class of targeted protein therapeutics for the treatment of Lysosomal Storage Diseases using the Company's proprietary Glycosylation Independent Lysosomal Targeting technology, today announced that it has received clearance from the U. S. Food and Drug Administration to proceed into a clinical trial for its first drug candidate, ZC-701, an enzyme replacement therapy for the treatment of Pompe disease.
As of 24 May 2004, the health authorities of Yambio County have reported a total of 19 cases, including 4 deaths, of Ebola haemorrhagic fever (EHF) in Yambio, Western Equatoria, south Sudan.
Targeted neuromodulation tailored to individual patients' distinctive symptoms is an increasingly common way of correcting misfiring brain circuits in people with epilepsy or Parkinson's disease.
Two studies in the November 17 issue of JAMA examine the change in prostate-specific antigen (PSA) screening and prostate cancer incidence before and after the 2012 U.S. Preventive Services Task Force (USPSTF) screening recommendations.
› Verified 5 days ago
News Archive
Adhering to a Mediterranean-type diet (MedDi) does not appear associated with the time to clinical onset of Huntington disease (phenoconversion), according to a study by Karen Marder, M.D., M.P.H., of Columbia University College of Physicians and Surgeons, New York, N.Y., and colleagues.
ZyStor Therapeutics, Inc., a biotechnology company developing a new class of targeted protein therapeutics for the treatment of Lysosomal Storage Diseases using the Company's proprietary Glycosylation Independent Lysosomal Targeting technology, today announced that it has received clearance from the U. S. Food and Drug Administration to proceed into a clinical trial for its first drug candidate, ZC-701, an enzyme replacement therapy for the treatment of Pompe disease.
As of 24 May 2004, the health authorities of Yambio County have reported a total of 19 cases, including 4 deaths, of Ebola haemorrhagic fever (EHF) in Yambio, Western Equatoria, south Sudan.
Targeted neuromodulation tailored to individual patients' distinctive symptoms is an increasingly common way of correcting misfiring brain circuits in people with epilepsy or Parkinson's disease.
Two studies in the November 17 issue of JAMA examine the change in prostate-specific antigen (PSA) screening and prostate cancer incidence before and after the 2012 U.S. Preventive Services Task Force (USPSTF) screening recommendations.
› Verified 5 days ago
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 9143 Philips Hwy 280, Jacksonville, Florida 32256 Phone: (904) 363-3200 | |
Jc Home Medical Type: Durable Medical Equipment & Medical Supplies Supplier Location: 9309 Old Kings Rd S, Jacksonville, Florida 32257 Phone: (904) 448-9827 | |
Publix Pharmacy #0849 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2033 Riverside Ave, Jacksonville, Florida 32204 Phone: (904) 381-1162 | |
Cvs Pharmacy # 03658 Type: Pharmacy Location: 11900 Mccormick Rd, Jacksonville, Florida 32225 Phone: (904) 642-7460 | |
Cvs Pharmacy # 03648 Type: Pharmacy Location: 3634 Rogero Rd, Jacksonville, Florida 32277 Phone: (904) 744-8414 |